Evaluating safety and cost-effectiveness of platelets stored in additive solution (PAS-F) as a hemolysis risk mitigation strategy.
Monica B PaganoBrennan L KatchatagShiva KhoobyariMark Van GerwenNina SenN Rebecca HaleyTerry B GernsheimerJohn R HessRyan A MetcalfPublished in: Transfusion (2018)
The use of PAS decreases plasma isoagglutinin titers, transfusion reactions, and is cost-effective when compared to routine plasma reduction as a strategy to mitigate hemolysis risk from minor incompatible platelet transfusion.